Indeed, mice deficient in NIK activity (e.g., NIKaly/aly mice) are protected from diverse forms of tissue injury [12,13] and small molecule NIK inhibitors are under preclinical development and have so far been shown to protect from tissue injury in murine lupus [14]. Here, MAP3K14 is linked to systemic lupus erythematosus.